EUDA Health (NASDAQ: EUDA) files Form 6-K furnishing October 23 press release
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
EUDA Health Holdings Limited submitted a Form 6-K as a foreign private issuer for October 2025. The filing notes that on October 23, 2025, the company issued a press release, which is attached as Exhibit 99.1, and was signed by Chief Executive Officer Alfred Lim.
Positive
- None.
Negative
- None.
FAQ
What did EUDA (EUDA) report in its October 2025 Form 6-K?
EUDA Health Holdings Limited reported that it issued a press release on October 23, 2025. The press release is attached as Exhibit 99.1, and the Form 6-K is signed by Chief Executive Officer Alfred Lim.
What is the main purpose of EUDA (EUDA)'s October 2025 Form 6-K?
The main purpose is to furnish a company press release dated October 23, 2025 as Exhibit 99.1. This keeps investors informed of material information released by EUDA Health Holdings Limited to the market.
Who signed EUDA (EUDA)'s October 23, 2025 Form 6-K filing?
The Form 6-K was signed on behalf of EUDA Health Holdings Limited by Alfred Lim. He is identified in the filing as the company’s Chief Executive Officer and authorized signatory under the Securities Exchange Act of 1934.
Which exhibit is attached to EUDA (EUDA)'s October 2025 Form 6-K?
The Form 6-K includes a press release attached as Exhibit 99.1. The filing explains that EUDA Health Holdings Limited issued this press release on October 23, 2025, and is furnishing it to investors through the report.
Where is EUDA Health Holdings Limited based according to the Form 6-K?
EUDA Health Holdings Limited lists its principal executive offices at 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979. The filing also provides a Singapore telephone contact number with the country code +65.